ASN
GNOM icon

Advisory Services Network’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Advisory Services Network’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-125
Closed -$12K – 1958
2020
Q4 		$12K Buy
+125
New +$10.5K ﹤0.01% 2343

Other funds holding GNOM

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Advisory Services Network's GNOM Position: Q1 2021 in Review

Advisory Services Network sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2021, closing a stake of 125 shares — an estimated $12K sold.

Advisory Services Network first reported a position in GNOM in Q4 2020 and held it in 1 quarter. The position peaked at $12K in Q4 2020. 38 funds tracked by Wall St. Rank hold GNOM as of Q1 2021.

  • Advisory Services Network reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
  • Advisory Services Network sold 125 Global X Genomics & Biotechnology ETF shares in Q1 2021, an estimated $12K.
  • Advisory Services Network first reported a position in Global X Genomics & Biotechnology ETF in Q4 2020 and held it in 1 quarter.
  • Advisory Services Network's Global X Genomics & Biotechnology ETF position peaked at $12K in Q4 2020.
  • 38 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.